declares having received consulting honoraria from Amgen, Boehringer Ingelheim, Merck, Pfizer, Aegerion, Novartis, Sanofi, Takeda, Novo Nordisk and Bayer, and research grants from British Heart Foundation, MRC (UK), NIHR, PHE, MSD, Pfizer, Aegerion, Colgate and Roche
Patients with Duchenne dystrophy and Becker dystrophy showed lower carnitine levels in muscle biopsies than controls [131] though these levels were higher than in patients suffering primary carnitine deficiency as a result of severe muscle damage [1]
The essential vitamin also ensures these cells are the proper shape and size to transport oxygen throughout the body
So your takeaway is the evidence leans in your favor, but how much depends on what youd otherwise be taking. Worth a real conversation with whoever manages your diabetes, not a reason to panic or to celebrate
Tirzepatide is a dual GLP-1 and GIP agonist, and semaglutide is a GLP-1 agonist
The mechanism of action does not directly involve the coagulation cascade or platelet function, which has led to questions about whether these medications might influence thrombotic risk